Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 17 of 17

List	Outcome	Time frame
Primary	Treatment titration and switch regimens as described by the prescribing clinician	Baseline and up to 20 weeks
Secondary	Adverse events (AEs)	Baseline and up to 20 weeks
Secondary	Change in participant weight	Baseline and up to 20 weeks
Secondary	Clinical Global Impressions - Improvement (CGI-I) score	Baseline and up to 20 weeks
Secondary	Number of schizophrenia-related relapses (defined as schizophrenia-related emergency department visits and/or hospitalizations and symptoms	Baseline and up to 20 weeks
Secondary	Continuation of treatment with xanomeline and trospium chloride (KarXT) at End of Study	Baseline and up to 20 weeks
Secondary	Number of participants who discontinue treatment, time to discontinuation, and reasons for discontinuation	Baseline and up to 20 weeks
Secondary	Number of participants using antiemetic treatment by type, duration, and resolution of event for xanomeline and trospium chloride (KarXT) related gastro-intestinal (GI) symptoms	Baseline and up to 20 weeks
Secondary	Date of first xanomeline and trospium chloride (KarXT) treatment	Baseline
Secondary	Participant age	Baseline
Secondary	Participant sex	Baseline
Secondary	Participant race	Baseline
Secondary	Participant ethnicity	Baseline
Secondary	Participant height	Baseline
Secondary	Participant's family history of schizophrenia	Baseline
Secondary	Duration since diagnosis of schizophrenia	Baseline
Secondary	Previous treatment(s) received for schizophrenia	Baseline

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07379827/registered